Shuttle Pharma to present at Planet MicroCap Showcase VEGAS 2025 on April 23

Shuttle Pharmaceuticals Holdings, Inc.

Presentation by Dr. Anatoly Dritschilo on April 23 at 2:30 PM PT at Planet MicroCap Showcase VEGAS 2025.
Focus on Phase 2 trial update of Ropidoxuridine + RT for glioblastoma and Shuttle Diagnostics advancements for prostate cancer.
Company will also conduct 1x1 meetings on April 24 at the conference.
No financial results or material changes announced.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.